
Canthnil Cap
NUFACE PHARMA - capsule - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Tranexa Tab.
You are viewing
Tranexa Tab
tablet - 10 S
₹180
₹18.00 per tablet
Canixa Life Sciences Pvt. Ltd. · tablet - 10 S · Rx
₹176
₹17.60 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Tranexa Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
Tranexamic acid 500 mg (tablet)
Treatment and prevention of bleeding due to excessive fibrinolysis such as heavy menstrual bleeding (menorrhagia), bleeding after dental procedures in haemophilia, nosebleeds, and other minor surgical/traumatic bleeding as prescribed
Tranexamic acid is an antifibrinolytic that blocks the binding of plasminogen to fibrin, preventing formation of plasmin. This stabilizes blood clots and reduces ongoing bleeding.
Take by mouth as directed by a physician. Swallow the tablet with water, with or without food; taking with food may reduce stomach upset. Dose and duration depend on the bleeding condition (e.g., for heavy menstrual bleeding it is typically taken only during bleeding days).
Common side effects of Tranexa Tab may include:

NUFACE PHARMA - capsule - 10 S
Standard delivery

NUFACE PHARMA - shampoo - 100 ml
Standard delivery

NUFACE PHARMA - capsule - 10 S
Standard delivery

NUFACE PHARMA - cream - 30 g
Standard delivery

NUFACE PHARMA - 60 ml
Standard delivery
NUFACE PHARMA - tablet - 10 S
Standard delivery

NUFACE PHARMA - capsule - 100 mg - 10 S
Standard delivery
NUFACE PHARMA - capsule - 200 mg - 10 S
Standard delivery
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Do not use in active intravascular clotting, history of thrombosis/thromboembolism unless advised by doctor, or with subarachnoid haemorrhage. Use with caution in kidney disease (dose adjustment needed) and in patients with risk factors for blood clots. Seek urgent care for chest pain, shortness of breath, leg swelling, sudden vision changes or severe headache. Avoid use for hematuria from upper urinary tract (risk of ureteral obstruction by clots).